"It could be that the mutation is in a regulatory region of the unidentified gene, such as within an intron or the promoter," Das said. Once they find it, they can begin development of a gene therapy approach to treating the condition, a strategy found successful by Aguirre's group multiple times in dogs. This could find application in humans as well. The study was published in the journal PLOS ONE.